CT perfusion for response evaluation after interventional ablation of hepatocellular carcinoma: a prospective study
Open Access
- 23 November 2021
- journal article
- research article
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 52 (1) , 1-9
Abstract
Background: Computed tomography (CT) perfusion was found to be useful in assessing treatment response in a variety of cancers through the evaluation in the arterial perfusion changes. We investigated the performance of CT perfusion parameters for assessment of hepatocellular carcinoma (HCC) response to radiofrequency ablation (RFA) and trans-arterial chemoembolization (TACE). We conducted a prospective diagnostic test accuracy study that recruited 70 HCC patients who were scheduled to undergo TACE or RFA. For each dynamic CT scan acquisition, four single perfusion CT image maps were generated, including functional maps of blood flow (BF), blood volume (BV), mean transit time (MTT), and permeability surface (PS). Results: In TACE-treated lesions, the BV achieved a sensitivity and specific of 100% and 83.3%, at a cutoff level of ≤ 122 ml/min/100 gm, for responders. Likewise, at a cutoff level of > 10 s, transit time had a sensitivity of 90.5% and specificity of 100%. At a cutoff level of ≤ 14 ml/min/100 gm, the PS had a sensitivity of 100% and specificity of 83.33% for responders. In RFA-treated lesions, at a cutoff level of ≤ 170 ml/min/100 gm and ≤ 11 ml/100 gm, the BF and BV had a sensitivity of 100% and specificity 100%, respectively, for responders. At a cutoff level of ≤ 11 ml/min/100 gm, PS had a sensitivity 77.27% and specificity 80%. Conclusions: The present study confirms the feasibility of CT perfusion for assessment of response to TACE and RFA among patients with HCC.Keywords
This publication has 25 references indexed in Scilit:
- Computed Tomographic Perfusion Imaging for the Prediction of Response and Survival to Transarterial Radioembolization of Liver MetastasesInvestigative Radiology, 2013
- Viable residual tumor tissue after radiofrequency ablation treatment in hepatocellular carcinoma: evaluation with CT perfusionAbdominal Radiology, 2012
- Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imagingEuropean Radiology, 2011
- The Etiology of Hepatocellular Carcinoma and Consequences for TreatmentThe Oncologist, 2010
- Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSeminars in Liver Disease, 2010
- Hepatocellular carcinoma: Assessment of response to transarterial chemoembolization with image subtractionJournal of Magnetic Resonance Imaging, 2010
- Assessment of Tumor Necrosis of Hepatocellular Carcinoma After Chemoembolization: Diffusion-Weighted and Contrast-Enhanced MRI With Histopathologic Correlation of the Explanted LiverAmerican Journal of Roentgenology, 2009
- Assessment of the hepatic microvascular changes in liver cirrhosis by perfusion computed tomographyWorld Journal of Gastroenterology, 2009
- Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinomaWorld Journal of Gastroenterology, 2008
- The Role of Functional MR Imaging in the Assessment of Tumor Response after Chemoembolization in Patients with Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2006